Cargando…

High HPgV replication is associated with improved surrogate markers of HIV progression

BACKGROUND: Human Pegivirus (HPgV) may have a beneficial effect on HIV disease progression in co-infected patients; however, the virologic characteristics of this infection are not well defined. In this study, we determined HPgV viremia prevalence in Mexico and provide new insights to understand HPg...

Descripción completa

Detalles Bibliográficos
Autores principales: Horemheb-Rubio, Gibran, Ramos-Cervantes, Pilar, Arroyo-Figueroa, Hugo, Ávila-Ríos, Santiago, García-Morales, Claudia, Reyes-Terán, Gustavo, Escobedo, Galileo, Estrada, Gloria, García-Iglesias, Trinidad, Muñoz-Saucedo, Nayeli, Kershenobich, David, Ostrosky-Wegman, Patricia, Ruiz-Palacios, Guillermo M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598987/
https://www.ncbi.nlm.nih.gov/pubmed/28910347
http://dx.doi.org/10.1371/journal.pone.0184494
_version_ 1783264015031468032
author Horemheb-Rubio, Gibran
Ramos-Cervantes, Pilar
Arroyo-Figueroa, Hugo
Ávila-Ríos, Santiago
García-Morales, Claudia
Reyes-Terán, Gustavo
Escobedo, Galileo
Estrada, Gloria
García-Iglesias, Trinidad
Muñoz-Saucedo, Nayeli
Kershenobich, David
Ostrosky-Wegman, Patricia
Ruiz-Palacios, Guillermo M.
author_facet Horemheb-Rubio, Gibran
Ramos-Cervantes, Pilar
Arroyo-Figueroa, Hugo
Ávila-Ríos, Santiago
García-Morales, Claudia
Reyes-Terán, Gustavo
Escobedo, Galileo
Estrada, Gloria
García-Iglesias, Trinidad
Muñoz-Saucedo, Nayeli
Kershenobich, David
Ostrosky-Wegman, Patricia
Ruiz-Palacios, Guillermo M.
author_sort Horemheb-Rubio, Gibran
collection PubMed
description BACKGROUND: Human Pegivirus (HPgV) may have a beneficial effect on HIV disease progression in co-infected patients; however, the virologic characteristics of this infection are not well defined. In this study, we determined HPgV viremia prevalence in Mexico and provide new insights to understand HPgV infection and HPgV/HIV co-infection. METHODS: We analyzed and quantified 7,890 serum samples for HPgV viremia by One-Step RT-Real-Time PCR, 6,484 from healthy blood donors and 1,406 from HIV-infected patients. Data on HIV progression were obtained from patients’ records. HPgV genotyping was performed in 445 samples by nested PCR of the 5’URT region. Finite Mixture Models were used to identify clustering patterns of HPgV viremia in blood donors and co-infected antiretroviral (ART)-naïve patients. RESULTS: HPgV was detected in 2.98% of blood donors and 33% of HIV patients, with a wide range of viral loads. The most prevalent genotypes were 3 (58.6%)and 2 (33.7%). HPgV viral loads from healthy blood donors and HPgV/HIV+ ART-naïve co-infected patients were clustered into two component distributions, low and high, with a cut-off point of 5.07log(10) and 5.06log(10), respectively. High HPgV viremia was associated with improved surrogate markers of HIV infection, independent of the estimated duration of HIV infection or HIV treatment. CONCLUSIONS: HPgV prevalence in Mexico was similar to that reported for other countries. The prevalent genotypes could be related to Mexico’s geographic location and ethnicity, since genotype 2 is frequent in the United States and Europe and genotype 3 in Asia and Amerindian populations. HPgV viral load demonstrated two patterns of replication, low and high. The more pronounced beneficial response observed in co-infected patients with high HPgV viremia may explain discrepancies found between other studies. Mechanisms explaining high and low HPgV replication should be explored to determine whether the persistently elevated replication depends on host or viral factors.
format Online
Article
Text
id pubmed-5598987
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-55989872017-09-22 High HPgV replication is associated with improved surrogate markers of HIV progression Horemheb-Rubio, Gibran Ramos-Cervantes, Pilar Arroyo-Figueroa, Hugo Ávila-Ríos, Santiago García-Morales, Claudia Reyes-Terán, Gustavo Escobedo, Galileo Estrada, Gloria García-Iglesias, Trinidad Muñoz-Saucedo, Nayeli Kershenobich, David Ostrosky-Wegman, Patricia Ruiz-Palacios, Guillermo M. PLoS One Research Article BACKGROUND: Human Pegivirus (HPgV) may have a beneficial effect on HIV disease progression in co-infected patients; however, the virologic characteristics of this infection are not well defined. In this study, we determined HPgV viremia prevalence in Mexico and provide new insights to understand HPgV infection and HPgV/HIV co-infection. METHODS: We analyzed and quantified 7,890 serum samples for HPgV viremia by One-Step RT-Real-Time PCR, 6,484 from healthy blood donors and 1,406 from HIV-infected patients. Data on HIV progression were obtained from patients’ records. HPgV genotyping was performed in 445 samples by nested PCR of the 5’URT region. Finite Mixture Models were used to identify clustering patterns of HPgV viremia in blood donors and co-infected antiretroviral (ART)-naïve patients. RESULTS: HPgV was detected in 2.98% of blood donors and 33% of HIV patients, with a wide range of viral loads. The most prevalent genotypes were 3 (58.6%)and 2 (33.7%). HPgV viral loads from healthy blood donors and HPgV/HIV+ ART-naïve co-infected patients were clustered into two component distributions, low and high, with a cut-off point of 5.07log(10) and 5.06log(10), respectively. High HPgV viremia was associated with improved surrogate markers of HIV infection, independent of the estimated duration of HIV infection or HIV treatment. CONCLUSIONS: HPgV prevalence in Mexico was similar to that reported for other countries. The prevalent genotypes could be related to Mexico’s geographic location and ethnicity, since genotype 2 is frequent in the United States and Europe and genotype 3 in Asia and Amerindian populations. HPgV viral load demonstrated two patterns of replication, low and high. The more pronounced beneficial response observed in co-infected patients with high HPgV viremia may explain discrepancies found between other studies. Mechanisms explaining high and low HPgV replication should be explored to determine whether the persistently elevated replication depends on host or viral factors. Public Library of Science 2017-09-14 /pmc/articles/PMC5598987/ /pubmed/28910347 http://dx.doi.org/10.1371/journal.pone.0184494 Text en © 2017 Horemheb-Rubio et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Horemheb-Rubio, Gibran
Ramos-Cervantes, Pilar
Arroyo-Figueroa, Hugo
Ávila-Ríos, Santiago
García-Morales, Claudia
Reyes-Terán, Gustavo
Escobedo, Galileo
Estrada, Gloria
García-Iglesias, Trinidad
Muñoz-Saucedo, Nayeli
Kershenobich, David
Ostrosky-Wegman, Patricia
Ruiz-Palacios, Guillermo M.
High HPgV replication is associated with improved surrogate markers of HIV progression
title High HPgV replication is associated with improved surrogate markers of HIV progression
title_full High HPgV replication is associated with improved surrogate markers of HIV progression
title_fullStr High HPgV replication is associated with improved surrogate markers of HIV progression
title_full_unstemmed High HPgV replication is associated with improved surrogate markers of HIV progression
title_short High HPgV replication is associated with improved surrogate markers of HIV progression
title_sort high hpgv replication is associated with improved surrogate markers of hiv progression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598987/
https://www.ncbi.nlm.nih.gov/pubmed/28910347
http://dx.doi.org/10.1371/journal.pone.0184494
work_keys_str_mv AT horemhebrubiogibran highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression
AT ramoscervantespilar highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression
AT arroyofigueroahugo highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression
AT avilariossantiago highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression
AT garciamoralesclaudia highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression
AT reyesterangustavo highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression
AT escobedogalileo highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression
AT estradagloria highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression
AT garciaiglesiastrinidad highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression
AT munozsaucedonayeli highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression
AT kershenobichdavid highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression
AT ostroskywegmanpatricia highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression
AT ruizpalaciosguillermom highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression